Heliyon (Jan 2022)

Impact of untreated diabetes and COVID-19-related diabetes on severe COVID-19

  • Emi Ushigome,
  • Masahide Hamaguchi,
  • Kazuki Sudo,
  • Nobuko Kitagawa,
  • Yuriko Kondo,
  • Dan Imai,
  • Tomohito Hattori,
  • Takaaki Matsui,
  • Masahiro Yamazaki,
  • Teiji Sawa,
  • Michiaki Fukui

Journal volume & issue
Vol. 8, no. 1
p. e08801

Abstract

Read online

Diabetes is a common comorbidity in patients with coronavirus disease (COVID-19) and contributes significantly to COVID-19 severity. We aimed to investigate the association between diabetic status and severe COVID-19. This prospective study included all COVID-19 patients admitted to our hospital, who were divided into four groups according to their diabetic status: no diabetes, treated diabetes, untreated diabetes, and COVID-19-related diabetes. Severe COVID-19 was defined as a condition that required the use of a ventilator. Of the 114 patients included in this study, 26 had severe COVID-19. The adjusted odds ratio (OR; 95% confidence interval [CI]) for severe COVID-19 was significantly higher in the treated diabetes, untreated diabetes, and COVID-19-related diabetes groups than in the no diabetes group (OR: 5.9, 95% CI [1.2–27.9]; OR 12.6, 95% CI [1.8–86.4]; and OR: 9.3, 95% [1.1–81.4], respectively). Findings from this study showed that the risk of severe COVID-19 was increased in treated diabetes, untreated diabetes, and COVID-19-related diabetes compared to no diabetes. Furthermore, the OR for severe COVID-19 was greater in untreated diabetes and COVID-19-related diabetes than in treated diabetes.

Keywords